Prognostic implications of residual disease (RD) tumor-infiltrating lymphocytes (TIL) in triple negative breast cancer (TNBC) after neo-adjuvant chemotherapy (NAC).

被引：0
|
作者：
Luen, Stephen James
Salgado, Roberto
Dieci, Maria Vittoria
Vingiani, Andrea
Curigliano, Giuseppe
Hubbard, Rebekah
Altamirano, Carlos Castaneda
Sanchez, Joselyn
D'Alfonso, Timothy
Cheng, Esther
Garcia, Miluska Castillo
Adams, Sylvia
Ahmed, Fahad
Rimm, David L.
Demaria, Sandra
Symmans, William Fraser
Michiels, Stefan
Loi, Sherene
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Inst Jules Bordet, Brussels, Belgium
[3] Univ Padua, Padua, Italy
[4] Ist Oncol Veneto IRCCS, Padua, Italy
[5] Ist Eur Oncol, Milan, Italy
[6] Univ Milan, Ist Eur Oncol, Milan, Italy
[7] Univ Texas MD Anderson Canc Ctr, Div Pathol, Houston, TX 77030 USA
[8] Inst Nacl Enfermedades Neoplas, Lima, Peru
[9] Cornell Univ, New York, NY 10021 USA
[10] NYU, Sch Med, Perlmutter Canc Ctr, New York, NY USA
[11] Yale Univ, New Haven, CT USA
[12] Yale Sch Med, New Haven, CT USA
[13] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY USA
[14] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[15] Inst Gustave Roussy, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.571
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
571
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prognostic value of tumor-infiltrating lymphocytes in patients with early-stage triple-negative breast cancers (TNBC) who did not receive adjuvant chemotherapy
    Park, J. H.
    Jonas, S. F.
    Bataillon, G.
    Criscitiello, C.
    Salgado, R.
    Loi, S.
    Viale, G.
    Lee, H. J.
    Dieci, M. V.
    Kim, S. -B.
    Vincent-Salomon, A.
    Curigliano, G.
    Andre, F.
    Michiels, S.
    ANNALS OF ONCOLOGY, 2019, 30 (12) : 1941 - 1949
  • [22] Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
    Leon-Ferre, Roberto A.
    Jonas, Sarah Flora
    Salgado, Roberto
    Loi, Sherene
    de Jong, Vincent
    Carter, Jodi M.
    Nielsen, Torsten O.
    Leung, Samuel
    Riaz, Nazia
    Chia, Stephen
    Jules-Clement, Gerome
    Curigliano, Giuseppe
    Criscitiello, Carmen
    Cockenpot, Vincent
    Lambertini, Matteo
    Suman, Vera J.
    Linderholm, Barbro
    Martens, John W. M.
    van Deurzen, Carolien H. M.
    Timmermans, A. Mieke
    Shimoi, Tatsunori
    Yazaki, Shu
    Yoshida, Masayuki
    Kim, Sung-Bae
    Lee, Hee Jin
    Dieci, Maria Vittoria
    Bataillon, Guillaume
    Vincent-Salomon, Anne
    Andre, Fabrice
    Kok, Marleen
    Linn, Sabine C.
    Goetz, Matthew P.
    Michiels, Stefan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (13): : 1135 - 1144
  • [23] Changes in Tumor-infiltrating Lymphocytes After Neoadjuvant Chemotherapy and Clinical Significance in Triple Negative Breast Cancer
    Lee, Hyun
    Lee, Miseon
    Seo, Jeong-Han
    Gong, Gyungyub
    Lee, Hee Jin
    ANTICANCER RESEARCH, 2020, 40 (04) : 1883 - 1890
  • [24] Prognostic Impact of Intratumoral Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
    Koga, Makiko
    Watanabe, Takanori
    Kozu, Keita
    Kato, Kimi
    Miyai, Kosuke
    Katsurada, Yuka
    Kumazawa, Fumihisa
    Sato, Kimiya
    Einama, Takahiro
    Yamasaki, Tamio
    Ueno, Hideki
    Kishi, Yoji
    Tsuda, Hitoshi
    CANCER SCIENCE, 2024, 115 : 2113 - 2113
  • [25] Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer
    Tu, Hengjia
    Zhang, Yuzhuo
    You, Zhixuan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (04):
  • [26] Prognostic Assessment of Stromal and Non-Stromal Tumor-Infiltrating Lymphocytes (TILs) in Triple-Negative Breast Cancer (TNBC)
    Ghosh, Toshi
    Goetz, Matthew
    Leon-Ferre, Roberto A.
    Liu, Heshan
    Polley, Mei-Yin C.
    Ingle, James
    Cafourek, Victoria L.
    Hillman, David W.
    Carter, Jodi
    Visscher, Daniel
    LABORATORY INVESTIGATION, 2018, 98 : 61 - 62
  • [27] Prognostic Assessment of Stromal and Non-Stromal Tumor-Infiltrating Lymphocytes (TILs) in Triple-Negative Breast Cancer (TNBC)
    Ghosh, Toshi
    Goetz, Matthew
    Leon-Ferre, Roberto A.
    Liu, Heshan
    Polley, Mei-Yin C.
    Ingle, James
    Cafourek, Victoria L.
    Hillman, David W.
    Carter, Jodi
    Visscher, Daniel
    MODERN PATHOLOGY, 2018, 31 : 61 - 62
  • [28] Response to subsequent therapies after failure to achieve pathologic complete response (pCR) after neo-adjuvant chemotherapy (NAC) in patients (pts) with triple negative breast cancer (TNBC)
    Pahuja, Shalu
    McGuire, Kandace
    Davidson, Nancy
    Brufsky, Adam
    Rastogi, Priya
    Jankowitz, Rachel
    Lembersky, Barry
    Puhalla, Shannon
    CANCER RESEARCH, 2015, 75
  • [29] Tumor-Infiltrating Lymphocyte (TIL) Assessment Distilled into Two Binary Parameters in Triple-Negative Breast Cancer (TNBC)
    Cui, Xiaoyan
    McIntire, Patrick J.
    Ginter, Paula
    Irshaid, Lina
    Chen, Zhengming
    Shin, Sandra J.
    MODERN PATHOLOGY, 2017, 30 : 37A - 37A
  • [30] Tumor-Infiltrating Lymphocyte (TIL) Assessment Distilled into Two Binary Parameters in Triple-Negative Breast Cancer (TNBC)
    Cui, Xiaoyan
    McIntire, Patrick J.
    Ginter, Paula
    Irshaid, Lina
    Chen, Zhengming
    Shin, Sandra J.
    LABORATORY INVESTIGATION, 2017, 97 : 37A - 37A
12345